Rich valuation amid rising uncertainty in demand from the US, its largest market, is expected to keep the stock range-bound in the short term, while sustained momentum in deal wins and expected margin expansion will keep long-term prospects intact.
Nifty records worst February month since Covid-19 with 6% loss
Nifty suffered its worst February decline since 2020, dropping 5.9% amid a broad sell-off, primarily in IT, auto, and pharma stocks. The index is down